Company intelligence / Profile preview
LifeBiotic
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
Overview
LifeBiotic is an Israeli biotechnology company specializing in the development of evidence-based botanical formulas designed to support cancer patients undergoing conventional treatments. The company's flagship product, Protectival (LCS101), is a proprietary blend of herbal extracts clinically studied for its ability to reduce the hematological side effects of chemotherapy, such as anemia and neutropenia. LifeBiotic focuses on bridging the gap between traditional herbal medicine and modern oncology through rigorous clinical research and standardized manufacturing. Their products are used globally to improve the quality of life and treatment compliance for individuals facing oncological challenges.
- Therapeutic areas
- HematologyOncology
- Modalities
- Botanical extract
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on LifeBiotic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LifeBiotic.